Election of new internal members of the Cochrane Governing Board

Transcription

1 Election of new internal members of the Cochrane Governing Board

2

3

4

5

6

7 Conflict of interest declaration: Peter C. Gøtzsche 1. Financial interests a) Received research funding: any grant, contract or gift, commissioned research, or fellowship from The Cochrane Collaboration or a related organisation (i.e. any organisation related to health care or medical research) to conduct research? Yes, 2011 and 2012, The Cochrane Collaboration, for methodological research. b) Had paid consultancies: any paid work, consulting fees (in cash or kind) from a related organisation? c) Received honoraria: one-time payments (in cash or kind) from a related organisation? d) Served as a director, officer, partner, trustee, employee or held a position of management with a related organisation? e) Possessed share-holdings, stock, stock options, equity with a related organisation (excludes mutual funds or similar arrangements where the individual has no control over the selection of the shares)? f) Received personal gifts from a related organisation? g) Had an outstanding loan with a related organisation? h) Received royalty payments from a related organisation? 2. Do you have any other competing interests that could pose a conflict of interest that would reasonably appear to be related to the primary interest?

8 Governing Board The Cochrane Collaboration, December 05, 2016 mination of Peter C Gøtzsche to the Governing Board of the Cochrane Collaboration I am writing this letter to show my support for Peter Gøtzsche s wish to join the Governing Board of the Cochrane Collaboration. As the author of a short history of the Collaboration, I believe I have a privileged outsider s view of Cochrane, having spent a decade attending the annual Colloquia and then several years conducting interviews both inside and outside the organization. In the course of this research Dr. Gøtzsche was one of over 200 interviewees who shared with me a unique perspective of the organization, its history and its future. I support this appointment because I think Peter brings not just an extensive knowledge of the practice of creating systematic reviews, but also a depth and breadth of experience in disseminating that knowledge to a broader audience. Dr. Gøtzsche s extensive and prolonged involvement in the Collaboration is unassailable. His enthusiasm for an international Collaboration was enshrined in quick action in 1993 when he pushed to create the rdic Cochrane Centre, which, after the UK Centre in Oxford, was one of the first to fully commit to this international group. I know Peter quite well and share with him his desire for Cochrane to produce the most rigorous and effective reviews possible. To this end, those reviews must be intelligible and useable by clinicians and patients. Over the course of writing my book I heard many criticisms of the Collaboration, one of the strongest being that the reviews did not serve patients interests. I believe Peter s appointment to the Governing Board would be a vote for relevance and patientcentred reviews that address conditions important to patients. Peter is a fierce opponent to the way medicine has been infected by conflicts of interest and biased medical knowledge. He will, I m sure he will continue to strongly voice those concerns as a member of the Governing Board. Iain Chalmers told me that he thought one of the long-lasting legacies of the Collaboration was a spirit of generosity. I believe that Peter understands, intrinsically, what motivates many of the thousands of volunteers around the globe and how they are the soul of Cochrane. I am confident that with Peter on the Governing Board, the organization will continue to grow and thrive, remembering its past, cultivating this spirit and ultimately remaining focused on the public interest. Sincerely, Alan Cassels Author, The Cochrane Collaboration: Medicines Best Kept Secret 423 Stannard Avenue, Victoria, BC. V8S 3M6 Canada

9 Cochrane Germany MEDICAL CENTER - UNIVERSITY OF FREIBURG Cochrane Germany Berliner Allee Freiburg Germany To whom it may concern Direct or: Prof. Dr. Gerd Antes Phone +49 (0) antes@cochrane.de Co-Dir ector : Dr. Joerg Meerpohl, MD Phone +49 (0) Fax +49 (0) meerpohl@cochrane.de Freiburg, Statement in support of Peter Gøtzsche s nomination as internal member of the Cochrane Governing Board It is my pleasure to support the nomination of Prof Peter Gøtzsche as internal member of the Cochrane Governing Board. Capacity in which I know Peter Gøtzsche I have known Peter personally since 2010 when I first met him at the Center & Branch Directors Meeting in Split, Croatia. Since then, we regularly met at the Center & Branch Directors Meetings which take place at the Colloquia and the Mid-Year Meetings. I do regard him very highly due to his thoughtful, sometimes critical input during these meetings and very much appreciate his expertise, experience, and vision with regard to any Cochranerelated matters. In my view, Peter is one of the few Cochrane people who are widely known to the outside world. Through his extraordinary work Peter personally has and still is contributing a great deal to the good reputation Cochrane is benefitting from today. Why I consider Peter Gøtzsche to be an appropriate candidate in the light of the job description and the extent to which I think he has the necessary attributes UNIVERSITÄTSKLINIKUM FREIBURG Anstalt des öffentlichen Rechts Sitz Freiburg Aufsichtsrat Vorsitzender: Ministerialdirigent Clemens Benz Vorstand Leitender Ärztlicher Direktor: Prof. Dr. Dr. h.c. mult. Jörg Rüdiger Siewert (Vorsitz) Stellvertretender Leitender Ärztlicher Direktor: Prof. Dr. Dr. Rainer Schmelzeisen Kaufmännischer Direktor : Bernd Sahner Dekan der Medizinischen Fakultät: Prof. Dr. Kerstin Krieglstein Pflegedirektor: Helmut Schiffer Bankverbindung Sparkasse Freiburg-Nördlicher Breisgau BLZ Konto-Nr IBAN DE BIC FRSPDE66

10 Peter has been involved with the Cochrane Collaboration from the very beginning as one of the most active and highly respected researchers, systematic review authors and as founding director of the rdic Cochrane Centre. Peter is very passionate about the Cochrane Collaboration and has dedicated his career to his work at the rdic Cochrane Center, which is one of the most successful and productive Centers within the Collaboration. He is author or co-author on more than a dozen Cochrane reviews and was a contributor to the 1 st version of the Cochrane Handbook. Peter has extensive managerial expertise and served on many high-level national as well as international committees or boards including the Cochrane Steering Group back in Peter was instrumental in setting up and supporting various other Cochrane Entities, such as the Branches of the rdic Cochrane Centre and methods groups including the n-randomized Methods Group. Peter also successfully hosted and led the Cochrane IMS team, which developed Archie and RevMan. Peter s most outstanding achievement is in my view his perseverance with the European Medicines Agency (EMA) including a complaint to the EU ombudsman that eventually led EMA to grant for the first time ever - access to clinical study reports and trial protocols. Peter s advocacy and contribution very positively impacted on the European Clinical Trials Directive. Peter s intricate knowledge of the widespread activities within Cochrane, and his very strong commitment to the goals of Cochrane, combined with his long-standing, successful expertise in leadership and advocacy make him a very strong candidate for the position of an internal member of the Cochrane Governing Board. Joerg J Meerpohl Co-Direct or Cochrane Germany Member, Cochrane Governing Board